Health leaders to discuss latest breast cancer findings at CTRC-AACR San Antonio Breast Cancer Symposium

Now in its 32nd year, the CTRC-AACR San Antonio Breast Cancer Symposium continues to attract the best in breast cancer science and world leaders from industry and academia with the goal of eradicating breast cancer.

This year, more than 8,500 scientists and other professionals will gather at the Henry B. Gonzales Convention Center in San Antonio from Dec. 9-13, 2009. The symposium is a partnership between the American Association for Cancer Research, the University of Texas Health Science Center and Baylor College of Medicine.

Last year, more than 8,000 people attended from 92 countries; 46 percent of the participants were medical doctors and 9 percent were basic research scientists. Last year was the first year the AACR partnered with the symposium in an effort to help increase the presence of basic science. As a result, the meeting began one day earlier than in past years and held standing room only scientific sessions.

"The San Antonio Breast Cancer Symposium is arguably the best cancer research meeting in the world, and with the addition of high quality science, credibility and outreach efforts from the American Association for Cancer Research, this collaboration continues to garner further scientific prominence," said C. Kent Osborne, M.D., director of the Dan L. Duncan Center and the Lester and Sue Smith Breast Center at Baylor College of Medicine and president of the symposium.

This year, in addition to the main program, the CTRC-AACR-SABCS press office will host four press conferences for the media highlighting important news from the meeting and a separate media Q&A on December 12 at 10:00 a.m. CT with Dennis Slamon, M.D., Ph.D. on the long-term survival, disease free survival and cardiac toxicity results from his latest research with Herceptin.

The following is a schedule of the press briefings.

  • Bisphosphonates: 12:30 p.m. CT, Thursday, Dec. 10
  • Drugs in the Pipeline: 8:00 a.m. CT, Friday, Dec. 11
  • New Treatment Paradigms: 12:30 p.m. CT, Friday, Dec. 11
  • Patient Management and Prognosis: 8:00 a.m. CT, Saturday, Dec. 12
  • Media Q&A with Dennis Slamon, M.D., Ph.D, 10:00 a.m. CT, Saturday, Dec. 12

Beyond the press conferences, the press office has selected additional abstracts that may be of interest to the media and will be highlighting them as separate press releases.

AACR will be conducting interviews with researchers throughout the symposium. Recordings of these events and interviews will be posted to AACR Scientific Podcast feed. You can subscribe to this feed through following links:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study shows cannabis as a genotoxic substance with cancer risks